CIPAN - Cia Ind Prom de Ant SA  

(Public, ELI:CPN)   Watch this stock  
Find more results for CPN
0.0900
0.0000 (0.00%)
Delayed:   4:30PM GMT+2
ELI data delayed by 15 mins - Disclaimer
Currency in EUR
Range     -
52 week 0.04 - 0.21
Open     -
Vol / Avg. 0.00/3,112.00
Mkt cap 2.20M
P/E     -
Div/yield     -
EPS     -
Shares 24.45M
Beta     -
Inst. own     -

Key stats and ratios

2010
Net profit margin - 0.24%
Operating margin - 4.89%
EBITD margin - 11.52%
Return on average assets - 0.17%
Return on average equity - 0.71%
Employees 146 -
Carbon Disclosure Rating - -

Address

Rua da Estacao, 42, Apartado 60 Vala do Carregado PO Box 60 Castanheira do Ribatejo
VILA FRANCA DE XIRA, 2601-906
Portugal
+351-263-856800 (Phone)
+351-263-855020 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

CIPAN Companhia Industrial Produtora de Antibioticos SA (CIPAN) is a Portugal-based company active in the pharmaceutical sector. The Company specializes in the research, development, production and commercialization of active pharmaceutical ingredients (API). Its activities include API fermentation and organic synthesis. The Company's products can be broken down into three categories: Fermentation, including potassium clavulanate and demeclocycline hydrochloride; Chemical Synthesis, representing the core products of the Company, including minocycline hydrochloride and doxycycline hyclate; as well as Sterile Products, such as potassium clavulanate. CIPAN�s chemical and downstream operations include ultrafiltration, nanofiltration, salt conversion and crystallization, among others. As of December 31, 2010 the Company was part of the AtralCipan Group.

Officers and directors

Sebastiao Alves Chairman of the Board
Luis Miguel Bairrada Lopes Chief Accounting Officer
Antonio Luis Martins Director
Sebastiao Manuel Tavares da Silva Alves Director
Jose Manuel Vieira Gavino Director